1.46EUR
405.55 MEUR
2.40 BEUR
349.68 M
About NOVONESIS A/S
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
Employees (FY)
6.76 K
ISIN
DK0060336014
FIGI
BBG000D79TW1
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NZM2 is 51.70 EUR — it has decreased by 1.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange NOVONESIS A/S stocks are traded under the ticker NZM2.
NOVONESIS A/S is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
NZM2 stock is 1.20% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is NOVONESIS A/S there?
NZM2 earnings for the last quarter are 0.45 EUR per share, whereas the estimation was 0.39 EUR resulting in a 16.84% surprise. The estimated earnings for the next quarter are 0.43 EUR per share. See more details about NOVONESIS A/S earnings.
NOVONESIS A/S revenue for the last quarter amounts to 596.05 M EUR despite the estimated figure of 589.50 M EUR. In the next quarter revenue is expected to reach 619.46 M EUR.
Yes, you can track NOVONESIS A/S financials in yearly and quarterly reports right on TradingView.
NZM2 stock has risen by 0.15% compared to the previous week, the month change is a 4.44% fall, over the last year NOVONESIS A/S has showed a 4.59% increase.
NZM2 net income for the last quarter is 93.61 M EUR, while the quarter before that showed 125.20 M EUR of net income which accounts for −25.23% change. Track more NOVONESIS A/S financial stats to get the full picture.
Today NOVONESIS A/S has the market capitalization of 24.13 B, it has increased by 0.66% over the last week.
NOVONESIS A/S dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NZM2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS A/S stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVONESIS A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS A/S technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS A/S stock shows the buy signal. See more of NOVONESIS A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVONESIS A/S future price: according to them, NZM2 price has a max estimate of 63.61 EUR and a min estimate of 46.87 EUR. Read a more detailed NOVONESIS A/S forecast: see what analysts think of NOVONESIS A/S and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS A/S EBITDA is 782.40 M EUR, and current EBITDA margin is 32.72%. See more stats in NOVONESIS A/S financial statements.